Product Categories
Country: | United States |
---|---|
Tel: | 781-+1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | info@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
Ibudilast;KC-404;MN-166;AV-411 | C14H18N2O | 50847-11-5 | Details |
Ispinesib;CK0238273;SB-715992 | C30H33ClN4O2 | 336113-53-2 | Details |
Mecamylamine hydrochloride;Mevasin;Inversine | C11H22ClN | 826-39-1 | Details |
AEE788;NVP-AEE 788 | C27H32N6 | 497839-62-0 | Details |
PF 03716556;PF-3716556 | C22H26N4O3 | 928774-43-0 | Details |
PI-3065;PI3065 | C27H31FN6OS | 955977-50-1 | Details |
Seliciclib;Roscovitine;R-roscovitine;CYC202 | C19H26N6O | 186692-46-6 | Details |
Parthenolide;(-)-Parthenolide | C15H20O3 | 20554-84-1 | Details |
M344;Histone Deacetylase Inhibitor III;MS 344 | C16H25N3O3 | 251456-60-7 | Details |
Fulvestrant;ZM 182780;ZD 9238;ICI 182780 | C32H47F5O3S | 129453-61-8 | Details |
Guanfacine hydrochloride;Tenex;Intuniv;Guanfacine | C9H10Cl3N3O | 29110-48-3 | Details |
4-amino-1,8-Naphthalimide | C12H8N2O2 | 1742-95-6 | Details |
Agerafenib;CEP-32496;RXDX-105;CEP 32496;CEP32496 | C24H22F3N5O5 | 1188910-76-0 | Details |
ELR510444;LR 510444;LR510444;LR-510444 | C19H16N2O2S2 | 1233948-35-0 | Details |
NS11394;NS 11394 | C23H19N3O | 951650-22-9 | Details |
Raf inhibitor 1;B-Raf inhibitor 1 | C26H19ClN8 | 1093100-40-3 | Details |
LB-100 | C13H20N2O4 | 1026680-07-8 | Details |
OF-1;OF 1;OF1 | C17H18BrN3O4S | 919973-83-4 | Details |
CaMKP Inhibitor | C10H8NNaO7S2 | 52789-62-5 | Details |
FH1;BRD-K4477;NSC 12407 | C17H18N2O2 | 2719-05-3 | Details |
Navitoclax;ABT-263 | C47H55ClF3N5O6S3 | 923564-51-6 | Details |
VER-82576;NVP-BEP800 | C21H23Cl2N5O2S | 847559-80-2 | Details |
Pexidartinib;PLX-3397 | C20H15ClF3N5 | 1029044-16-3 | Details |
Tyrphostin 23;RG-50810;TX 825;Tyrphostin A23;AG18 | C10H6N2O2 | 118409-57-7 | Details |
Methyl carbamate;Methylurethan;Urethylane | C2H5NO2 | 598-55-0 | Details |
Trametinib;JTP-74057;GSK1120212 | C26H23FIN5O4 | 871700-17-3 | Details |
MG-132;Z-Leu-Leu-Leu-CHO;MG132;MG 132;Z-LLL-al | C26H41N3O5 | 133407-82-6 | Details |
Temsirolimus;NSC 683864;CCI-779 | C56H87NO16 | 162635-04-3 | Details |
Fexinidazole;HOE 239 | C12H13N3O3S | 59729-37-2 | Details |
Atorvastatin | C33H35FN2O5 | 134523-00-5 | Details |
Eniporide | C14H16N4O3S | 176644-21-6 | Details |
Veliparib dihydrochloride;ABT-888 dihydrochloride | C13H16N4O | 912445-05-7 | Details |
LY2109761 | C26H27N5O2 | 700874-71-1 | Details |
Palosuran;ACT-058362 | C25H30N4O2 | 540769-28-6 | Details |
Fimepinostat;CUDC-907;CUDC 907;PI3K/HDAC Inhibitor | C23H24N8O4S | 1339928-25-4 | Details |
CDK4-IN-1 | C22H29ClN8 | 1256963-02-6 | Details |
Bioymifi;DR5 Activator | C22H12BrN3O4S | 1420071-30-2 | Details |
BET bromodomain inhibitor | C24H20ClN5O2 | 1505453-59-7 | Details |
LY2409881 trihydrochloride;LY2409881 | C24H30Cl2N6OS | 946518-60-1 | Details |
Suramin Sodium Salt;Suramin hexasodium salt;NF-060;BAY-205 | C51H34N6Na6O23S6 | 129-46-4 | Details |
Cardiogenol C | C13H16N4O2 | 671225-39-1 | Details |
Yohimbine hydrochloride;Yohimbine HCl;Antagonil | C21H27ClN2O3 | 65-19-0 | Details |
Framycetin sulfate;Framycetin sulphate;Neomycin Sulphate B | C23H48N6O17S | 4146-30-9 | Details |
Nutlin-3;Nutlin 3;Nutlin3 | C30H30Cl2N4O4 | 548472-68-0 | Details |
ABT-737;ABT737;ABT 737 | C42H45ClN6O5S2 | 852808-04-9 | Details |
Quizartinib;AC220 | C29H32N6O4S | 950769-58-1 | Details |
PHA-793887;PHA 793887;PHA793887 | C19H31N5O2 | 718630-59-2 | Details |
GSK2636771;GSK 2636771;GSK-2636771 | C22H22F3N3O3 | 1372540-25-4 | Details |
MCOPPB triHydrochloride;MCOPPB trihydrochlride;MCOPPB 3HCl | C26H43Cl3N4 | 1108147-88-1 | Details |
kb NB 142-70 | C11H9NO2S2 | 1233533-04-4 | Details |
AGI-5198;IDH-C35;AGI5198;AGI 5198 | C27H31FN4O2 | 1355326-35-0 | Details |
Purvalanol A;NG-60 | C19H25ClN6O | 212844-53-6 | Details |
Articaine hydrochloride;Ultracaine;Hoe-045;Articaine HCl | C13H20N2O3S.ClH | 23964-57-0 | Details |
Afatinib;Afatinib free base;BIBW 2992 | C24H25ClFN5O3 | 850140-72-6 | Details |
Ixazomib;MLN2238 | C14H19BCl2N2O4 | 1072833-77-2 | Details |
PSI-6206;GS-331007;PSI6206;2'-deoxy-2'-fluoro-2'-C-methyluridine;RO 2433 | C10H13FN2O5 | 863329-66-2 | Details |
CX-5461;CX5461 | C27H27N7O2S | 1138549-36-6 | Details |
Venetoclax;ABT 199;ABT199;GDC-0199;ABT-199 | C45H50ClN7O7S | 1257044-40-8 | Details |
LCL161 | C26H33FN4O3S | 1005342-46-0 | Details |
APD668;APD 668 | C21H24FN5O5S | 832714-46-2 | Details |
SW033291 | C21H20N2OS3 | 459147-39-8 | Details |
A 77-01;A77-01 | C18H14N4 | 607737-87-1 | Details |
Geniposidic Acid | C16H22O10 | 27741-01-1 | Details |
Bergapten;5-Methoxypsoralen | C12H8O4 | 484-20-8 | Details |
PQ401;IGF-1R Inhibitor II | C18H16ClN3O2 | 196868-63-0 | Details |
(+)-JQ-1;JQ1 | C23H25ClN4O2S | 1268524-70-4 | Details |
AF-353;Ro-4;AF 353 | C14H17IN4O2 | 865305-30-2 | Details |
GSK126;GSK2816126A;EZH2 inhibitor | C31H38N6O2 | 1346574-57-9 | Details |
ETP-46464;ETP46464 | C30H22N4O2 | 1345675-02-6 | Details |
BVT 2733 | C17H21ClN4O3S2 | 376640-41-4 | Details |
Dorzolamide hydrochloride;Dorzolamide HCl;MK507 hydrochloride;L671152 hydrochloride;MK-507 (L-671152) HCl | C10H17ClN2O4S3 | 130693-82-2 | Details |
Carbidopa monohydrate;S(-)-Carbidopa;Carbidopa Hydrate | C10H16N2O5 | 38821-49-7 | Details |
SC-514;GK 01140;SC514;SC 514 | C9H8N2OS2 | 354812-17-2 | Details |
SD-208;SD208;SD 208;ALK5 Inhibitor V | C17H10ClFN6 | 627536-09-8 | Details |
Magnesium Lithospermate B;Monomethyl lithospermate B;Lithospermate B | C36H28MgO16 | 122021-74-3 | Details |
Dibutyl carbonate | C9H18O3 | 542-52-9 | Details |
Danusertib;PHA-739358 | C26H30N6O3 | 827318-97-8 | Details |
Adavosertib;MK-1775;AZD1775;Adavosertib (MK-1775) | C27H32N8O2 | 955365-80-7 | Details |
WP1066 | C17H14BrN3O | 857064-38-1 | Details |
ELN-441958;ELN 441958 | C29H29ClN4O2 | 913064-47-8 | Details |
WS6 | C29H31F3N6O3 | 1421227-53-3 | Details |
APY0201 | C23H23N7O | 1232221-74-7 | Details |
TH287;TH287 hydrochloride | C11H10Cl2N4 | 1609960-30-6 | Details |
SBI-0206965;SBI 0206965;SBI0206965 | C21H21BrN4O5 | 1884220-36-3 | Details |
Buspirone hydrochloride;Buspirone HCl;Narol;Buspar | C21H32ClN5O2 | 33386-08-2 | Details |
Semaxinib;SU5416 | C15H14N2O | 204005-46-9 | Details |
Propidium Iodide;PI | C27H34IN4+ | 25535-16-4 | Details |
Pimavanserin;ACP-103 | C25H34FN3O2 | 706779-91-1 | Details |
PJ34 hydrochloride;PJ34 HCl | C17H17N3O2HCl | 344458-15-7 | Details |
Vinburnine;L-Eburnamonine;(-)-Eburnamonine;(-)-Vincamone;Vincamone;Eburnalritardo | C19H22N2O | 4880-88-0 | Details |
1-NM-PP1;PP1 Analog II;1 nM-PP1 | C20H21N5 | 221244-14-0 | Details |
Adenosine monophosphate;5'-Adenylic acid;Adenosine 5'-monophosphate;AMP | C10H14N5O7P | 61-19-8 | Details |
Sepantronium bromide;YM155 | C20H19BrN4O3 | 781661-94-7 | Details |
Thiazovivin | C15H13N5OS | 1226056-71-8 | Details |
Lexibulin;CYT-997 | C24H30N6O2 | 917111-44-5 | Details |
I-BET151;GSK1210151A | C23H21N5O3 | 1300031-49-5 | Details |
Amitifadine hydrochloride;DOV-21947 hydrochloride;EB-1010 hydrochloride | C11H12Cl3N | 410074-74-7 | Details |
Pyrazolo[1,5-a]pyrimidine 4h | C23H23N5O2 | 597544-21-3 | Details |
C-7280948;C7280948 | C14H16N2O2S | 587850-67-7 | Details |
Tacrolimus;FR900506;Fujimycin;FK506 | C44H69NO12 | 104987-11-3 | Details |
Product Total: Product Page: | ||||
84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 |